Robert Greenfield originally hails from New York and achieved his BA in Chemistry from SUNY at Buffalo and his PhD degree in biochemistry from Cornell University Medical College (New York). Rob completed four years of post doctoral training in immunology and virology and went on to a career spanning over thirty years in pharmaceutical research and development and diagnostics in the fields of cancer and hemostasis. Rob held senior research positions at Bristol Myers Squibb working on research and development of targeted cancer immunotherapies. Rob’s discovery of a unique targeted drug-immunoconjugate became the first biotechnology-based anti-cancer drug candidate brought into clinical trials at BMS. Rob was senior Director of Research and Development at American Diagnostica Inc/Sekisui Diagnostics (Stamford, CT) for over twelve years. He managed a large research department which was responsible for the development of patented in vitro diagnostic blood tests for hemostasis disorders. He was also involved in the commercialization of an in vitro prognostic test for breast cancer. Rob’s other professional accomplishments include over 35 peer reviewed publications and other professional articles and has over twenty patents and patent applications. Rob co-founded C-Term Diagnostics Ltd, a cancer diagnostic company, and two food science businesses Vitacyclix LLC and Vita-You Solutions LLC with a focus on vitamin D, nutrition and natural skincare. Rob currently serves as a senior executive and Chief Science Officer for Vita-You Solutions. He has developed novel skincare formulations and products for treating various problem dermatological conditions such as acne, fungal infections and eczema. He has also developed technology for water-solubilization of many fat-soluble vitamins and essential nutrients.